Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

4.4K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.4K
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

138
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
138
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

186
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
186
Framing Effects03:26

Framing Effects

7.4K
Information is everywhere and its presentation—such as how and when items are presented—can impact our perceptions and decisions surrounding the info. This broad concept umbrellas framing effects—influences that occur due to the way information is framed in its appearance, whether it’s purely the order or the specific wording of a message. Let’s take a look at numerous ways in which two versions of something can objectively say the same thing, yet we respond in...
7.4K
Hazard Ratio01:12

Hazard Ratio

122
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
122

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Offloading Adherence for Appearance's Sake?

Journal of the American Podiatric Medical Association·2026
Same author

Patient-reported outcomes after dorsal approach plantar plate repair with nine year follow up.

The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons·2026
Same author

Outpatient surgical fixation of complicated calcaneal fractures pose no excess risk for 30-day complications.

The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons·2024
Same author

Patient expectations in hallux valgus surgery: A qualitative analysis.

The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons·2024
Same author

Obesity is highly associated with a non-home discharge following total ankle arthroplasty.

The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons·2024
Same author

Prospective Surgical Cohort Analysis.

Clinics in podiatric medicine and surgery·2024

相关实验视频

Updated: Jul 2, 2025

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

6.0K

一本关于成本效益分析的入门书.

Rachel H Albright1, Adam E Fleischer2

  • 1Depatment of Surgery, Podiatry, Foot & Ankle Surgery, Stamford Health Medical Group, 800 Post Road, Suite 302, Darien, CT 06820, USA.

Clinics in podiatric medicine and surgery
|February 22, 2024
PubMed
概括
此摘要是机器生成的。

成本效益分析 (CEA) 通过比较治疗成本和有效性来简化医疗保健决策. 本综述涵盖了CEA的解释,它与成本分析的区别,以及它在医学研究中的意义.

关键词:
成本分析 成本分析对成本效益的分析.卫生经济学 卫生经济学

更多相关视频

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

408
The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.3K

相关实验视频

Last Updated: Jul 2, 2025

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

6.0K
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

408
The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.3K

科学领域:

  • 卫生经济学 卫生经济学
  • 决策科学 决策科学 决策科学
  • 医学研究方法学 医学研究方法学

背景情况:

  • 医疗保健决策涉及到竞争战略之间的复杂选择.
  • 需要有系统的方法来有效评估治疗选择.
  • 了解成本效益对于医疗保健的资源配置至关重要.

研究的目的:

  • 提供成本效益分析 (CEA) 的全面概述.
  • 阐明CEA的关键概念和属性.
  • 突出CEA在医学文献中的重要性.

主要方法:

  • 综述成本效益分析中的主要概念.
  • 结果的解释解释和不确定性.
  • 从简单的成本分析中区分CEA.

主要成果:

  • CEA系统地比较竞争性医疗保健策略的成本和有效性.
  • 了解CEA解释对于其应用至关重要.
  • 通过结合有效性结果,CEA与成本分析不同.

结论:

  • 成本效益分析是做出明智医疗决策的重要工具.
  • CEA为评估医疗保健干预提供了一个框架.
  • 这一综述强调了CEA对医学文献的重大贡献.